Altered protein expression profiles in umbilical veins: Insights into vascular dysfunctions of the children born after in vitro fertilization

Biology of Reproduction

Volumn 91, Issue 3, 2014, Pages

  Gao, Qian ^a,b   Pan, Hai Tao ^a,b   Lin, Xian Hua ^a   Zhang, Jun Yu ^c   Jiang, Ying ^a   Tian, Shen ^a   Chen, Lu Ting ^a   Liu, Miao E ^a   Xiong, Yi Meng ^a   Huang, He Feng ^a,c   Sheng, Jian Zhong ^a,b  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Cardiovascular; IPA; iTRAQ; IVF; Umbilical veins

Indexed keywords

ESTRADIOL; LUMICAN; VIMENTIN; KERATAN SULFATE; PROTEOCHONDROITIN SULFATE;

ADOLESCENT; ARTICLE; BIOINFORMATICS; CARBON METABOLISM; CHILD; CHILDHOOD DISEASE; CHINESE; COMPARATIVE STUDY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ESTRADIOL BLOOD LEVEL; FEMALE; FERTILIZATION IN VITRO; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; UMBILICAL CORD BLOOD; UMBILICAL VEIN; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR DISEASE; WESTERN BLOTTING; ADVERSE EFFECTS; BLOOD; CELL CULTURE; CHEMISTRY; CHINA; CYTOLOGY; FETUS BLOOD; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PRESCHOOL CHILD; RISK; UPREGULATION; VASCULAR DISEASES; VASCULAR ENDOTHELIUM;

ADOLESCENT; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; CHINA; CHONDROITIN SULFATE PROTEOGLYCANS; ENDOTHELIUM, VASCULAR; ESTRADIOL; FEMALE; FERTILIZATION IN VITRO; FETAL BLOOD; FOLLOW-UP STUDIES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; KERATAN SULFATE; MALE; RETROSPECTIVE STUDIES; RISK; UMBILICAL VEINS; UP-REGULATION; VASCULAR DISEASES; VIMENTIN;

EID: 84929516498     PISSN: 00063363     EISSN: 15297268     Source Type: Journal    
DOI: 10.1095/biolreprod.114.120659     Document Type: Article

References (47)

1. de Mouzon J, Goossens V, Bhattacharya S, Castilla JA, Ferraretti AP, Korsak V, Kupka M, Nygren KG, Nyboe Andersen A. Assisted reproductive technology in Europe, 2006: results generated from European registers by ESHRE. Hum Reprod 2010; 25:1851-1862.
2. Hansen M, Kurinczuk JJ, Bower C, Webb S. The risk of major birth defects after intracytoplasmic sperm injection and in vitro fertilization. N Engl J Med 2002; 346:725-730.
3. Klemetti R, Gissler M, Sevon T, Koivurova S, Ritvanen A, Hemminki E. Children born after assisted fertilization have an increased rate of major congenital anomalies. Fertil Steril 2005; 84:1300-1307.
4. Wen J, Jiang J, Ding C, Dai J, Liu Y, Xia Y, Liu J, Hu Z. Birth defects in children conceived by in vitro fertilization and intracytoplasmic sperm injection: a meta-analysis. Fertil Steril 2012; 97:1331-1337. e1-4.
5. Yan J, Huang G, Sun Y, Zhao X, Chen S, Zou S, Hao C, Quan S, Chen ZJ. Birth defects after assisted reproductive technologies in China: analysis of 15,405 offspring in seven centers (2004 to 2008). Fertil Steril 2011; 95:458-460.
6. Zechner U, Pliushch G, Schneider E, El Hajj N, Tresch A, Shufaro Y, Seidmann L, Coerdt W, Muller AM, Haaf T. Quantitative methylation analysis of developmentally important genes in human pregnancy losses after ART and spontaneous conception. Mol Hum Reprod 2010; 16:704-713.
7. Jacob S, Moley KH. Gametes and embryo epigenetic reprogramming affect developmental outcome: implication for assisted reproductive technologies. Pediatr Res 2005; 58:437-446.
8. Allen VM, Wilson RD, Cheung A. Pregnancy outcomes after assisted reproductive technology. J Obstet Gynaecol Can 2006; 28:220-250.
9. Schieve LA, Ferre C, Peterson HB, Macaluso M, Reynolds MA, Wright VC. Perinatal outcome among singleton infants conceived through assisted reproductive technology in the United States. Obstet Gynecol 2004; 103:1144-1153.
10. De Geyter C, De Geyter M, Steimann S, Zhang H, Holzgreve W. Comparative birth weights of singletons born after assisted reproduction and natural conception in previously infertile women. Hum Reprod 2006; 21:705-712.
11. Scherrer U, Rimoldi SF, Rexhaj E, Stuber T, Duplain H, Garcin S, de Marchi SF, Nicod P, Germond M, Allemann Y, Sartori C. Systemic and pulmonary vascular dysfunction in children conceived by assisted reproductive technologies. Circulation 2012; 125:1890-1896.
12. Valenzuela-Alcaraz B, Crispi F, Bijnens B, Cruz-Lemini M, Creus M, Sitges M, Bartrons J, Civico S, Balasch J, Gratacos E. Assisted reproductive technologies are associated with cardiovascular remodeling in utero that persists postnatally. Circulation 2013; 128:1442-1450.
13. Ceelen M, van Weissenbruch MM, Vermeiden JP, van Leeuwen FE, Delemarre-van de Waal HA. Cardiometabolic differences in children born after in vitro fertilization: follow-up study. J Clin Endocrinol Metab 2008; 93:1682-1688.
14. Sakka SD, Loutradis D, Kanaka-Gantenbein C, Margeli A, Papastamataki M, Papassotiriou I, Chrousos GP. Absence of insulin resistance and low-grade inflammation despite early metabolic syndrome manifestations in children born after in vitro fertilization. Fertil Steril 2010; 94:1693-1699.
15. Rexhaj E, Giacobino A, Nicod P, Germond M, Sartori C, Scherrer U. Mice generated by assisted reproductive technologies, a model organism for the study of epigenetic mechanisms of vascular dysfunction in vivo. Circulation 2010; 122:A19117.
16. Watkins AJ, Platt D, Papenbrock T, Wilkins A, Eckert JJ, Kwong WY, Osmond C, Hanson M, Fleming TP. Mouse embryo culture induces changes in postnatal phenotype including raised systolic blood pressure. Proc Natl Acad Sci U S A 2007; 104:5449-5454.
17. Huang HF, Sheng JZ. Gamete and Embryo-Fetal Origins of Adult Diseases. New York, NY: Springer; 2014.
18. Barker DJ. Fetal origins of coronary heart disease. BMJ 1995; 311:171-174.
19. Bateson P, Barker D, Clutton-Brock T, Deb D, D'Udine B, Foley RA, Gluckman P, Godfrey K, Kirkwood T, Lahr MM, McNamara J, Metcalfe NB, et al. Developmental plasticity and human health. Nature 2004; 430:419-421.
20. Eriksson JG, Forsen T, Tuomilehto J, Winter PD, Osmond C, Barker DJ. Catch-up growth in childhood and death from coronary heart disease: longitudinal study. BMJ 1999; 318:427-431.
21. Zhang Y, Zhang YL, Feng C, Wu YT, Liu AX, Sheng JZ, Cai J, Huang HF. Comparative proteomic analysis of human placenta derived from assisted reproductive technology. Proteomics 2008; 8:4344-4356.
22. Wu WW, Wang G, Baek SJ, Shen RF. Comparative study of three proteomic quantitative methods, DIGE, cICAT, and iTRAQ, using 2D gelor LC-MALDI TOF/TOF. J Proteome Res 2006; 5:651-658.
23. Wisniewski JR, Zougman A, Nagaraj N, Mann M. Universal sample preparation method for proteome analysis. Nat Methods 2009; 6:359-362.
24. Sheng Q, Dai J, Wu Y, Tang H, Zeng R. BuildSummary: using a group-based approach to improve the sensitivity of peptide/protein identification in shotgun proteomics. J Proteome Res 2012; 11:1494-1502.
25. Hall M, Frank E, Holmes G, Pfahringer B, Reutemann P, Witten IH. The WEKA data mining software: an update. ACM SIGKDD Explorations Newsletter 2009; 11:10-18.
26. Lyall F, Robson SC, Bulmer JN. Spiral artery remodeling and trophoblast invasion in preeclampsia and fetal growth restriction: relationship to clinical outcome. Hypertension 2013; 62:1046-1054.
27. Makhoul IR, Tamir A, Bader D, Rotschild A, Weintraub Z, Yurman S, Reich D, Bental Y, Jammalieh J, Smolkin T, Sujov P, Hochberg Z. In vitro fertilisation and use of ovulation enhancers may both influence childhood height in very low birthweight infants. Arch Dis Child Fetal Neonatal Ed 2009; 94:F355-F359.
28. Ceelen M, van Weissenbruch MM, Prein J, Smit JJ, Vermeiden JP, Spreeuwenberg M, van Leeuwen FE, Delemarre-van de Waal HA. Growth during infancy and early childhood in relation to blood pressure and body fat measures at age 8-18 years of IVF children and spontaneously conceived controls born to subfertile parents. Hum Reprod 2009; 24:2788-2795.
29. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004; 114(suppl 2):555-576.
30. He JB, Feng LL, Li J, Tao RJ, Ren YL, Wan J, He HW. Design, synthesis and molecular modeling of novel N-acylhydrazone derivatives as pyruvate dehydrogenase complex E1 inhibitors. Bioorg Med Chem 2014; 22:89-94.
31. Valdivia CR, Ueda K, Ackerman MJ, Makielski JC. GPD1L links redox state to cardiac excitability by PKC-dependent phosphorylation of the sodium channel SCN5A. Am J Physiol Heart Circ Physiol 2009; 297: H1446-H1452.
32. Jackson B, Brocker C, Thompson DC, Black W, Vasiliou K, Nebert DW, Vasiliou V. Update on the aldehyde dehydrogenase gene (ALDH) superfamily. Hum Genomics 2011; 5:283-303.
33. Im E, Venkatakrishnan A, Kazlauskas A. Cathepsin B regulates the intrinsic angiogenic threshold of endothelial cells. Mol Biol Cell 2005; 16:3488-3500.
34. Jarvelainen HT, Iruela-Arispe ML, Kinsella MG, Sandell LJ, Sage EH, Wight TN. Expression of decorin by sprouting bovine aortic endothelial cells exhibiting angiogenesis in vitro. Exp Cell Res 1992; 203:395-401.
35. Hibino S, Shibuya M, Hoffman MP, Engbring JA, Hossain R, Mochizuki M, Kudoh S, Nomizu M, Kleinman HK. Laminin alpha5 chain metastasis- and angiogenesis-inhibiting peptide blocks fibroblast growth factor 2 activity by binding to the heparan sulfate chains of CD44. Cancer Res 2005; 65:10494-10501.
36. Qian X, Wang TN, Rothman VL, Nicosia RF, Tuszynski GP. Thrombospondin-1 modulates angiogenesis in vitro by up-regulation of matrix metalloproteinase-9 in endothelial cells. Exp Cell Res 1997; 235:403-412.
37. Ballard VL, Sharma A, Duignan I, Holm JM, Chin A, Choi R, Hajjar KA, Wong SC, Edelberg JM. Vascular tenascin-C regulates cardiac endothelial phenotype and neovascularization. FASEB J 2006; 20:717-719.
38. Vasir B, Reitz P, Xu G, Sharma A, Bonner-Weir S, Weir GC. Effects of diabetes and hypoxia on gene markers of angiogenesis (HGF, cMET, uPA and uPAR, TGF-alpha, TGF-beta, bFGF and Vimentin) in cultured and transplanted rat islets. Diabetologia 2000; 43:763-772.
39. Kim MJ, Kwon JS, Suh SH, Suh JK, Jung J, Lee SN, Kim YH, Cho MC, Oh GT, Lee K. Transgenic overexpression of translationally controlled tumor protein induces systemic hypertension via repression of Na+,K+-ATPase. J Mol Cell Cardiol 2008; 44:151-159.
40. Weis SM, Zimmerman SD, Shah M, Covell JW, Omens JH, Ross J, Jr., Dalton N, Jones Y, Reed CC, Iozzo RV, McCulloch AD. A role for decorin in the remodeling of myocardial infarction. Matrix Biol 2005; 24:313-324.
41. Imanaka-Yoshida K, Hiroe M, Nishikawa T, Ishiyama S, Shimojo T, Ohta Y, Sakakura T, Yoshida T. Tenascin-C modulates adhesion of cardiomyocytes to extracellular matrix during tissue remodeling after myocardial infarction. Lab Invest 2001; 81:1015-1024.
42. Talusan P, Bedri S, Yang S, Kattapuram T, Silva N, Roughley PJ, Stone JR. Analysis of intimal proteoglycans in atherosclerosis-prone and atherosclerosis-resistant human arteries by mass spectrometry. Mol Cell Proteomics 2005; 4:1350-1357.
43. Schiffers PM, Henrion D, Boulanger CM, Colucci-Guyon E, Langa-Vuves F, van Essen H, Fazzi GE, Levy BI, De Mey JG. Altered flow-induced arterial remodeling in vimentin-deficient mice. Arterioscler Thromb Vasc Biol 2000; 20:611-616.
44. Zhang R, Shi L, Zhou L, Zhang G, Wu X, Shao F, Ma G, Ying K. Transgelin as a therapeutic target to prevent hypoxic pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 2014; 306: L574-L583.
45. Shang Y, Hu X, DiRenzo J, Lazar MA, Brown M. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 2000; 103:843-852.
46. Bonagura TW, Pepe GJ, Enders AC, Albrecht ED. Suppression of extravillous trophoblast vascular endothelial growth factor expression and uterine spiral artery invasion by estrogen during early baboon pregnancy. Endocrinology 2008; 149:5078-5087.
47. Hu XL, Feng C, Lin XH, Zhong ZX, Zhu YM, Lv PP, Lv M, Meng Y, Zhang D, Lu XE, Jin F, Sheng JZ, et al. High maternal serum estradiol environment in the first trimester is associated with the increased risk of small-for-gestational-age birth. J Clin Endocrinol Metab 2014; 99:2217-2224.